HAVRIX HEPATITIS A VACCINE PAED – 1

HAVRIX 720 IU is a vaccine used to prevent hepatitis A, a viral infection that affects the liver. It is specifically formulated for children and is administered in a single dose for pediatric patients. The vaccine works by stimulating the immune system to produce antibodies against the hepatitis A virus, thereby providing immunity and protecting against future infections.

Hepatitis A is primarily transmitted through the ingestion of contaminated food or water, making vaccination crucial for children, especially in areas where the virus is prevalent. HAVRIX is recommended for children aged 1 year and older, and it is particularly important for those traveling to regions with high rates of hepatitis A. The vaccine is safe and effective, significantly reducing the risk of contracting the virus. Overall, HAVRIX 720 IU plays a vital role in public health by preventing hepatitis A infections in the pediatric population.